✦ LIBER ✦

The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer

✍ Scribed by Cynthia R. Osborne; Anita Duncan; Scot Sedlacek; Devchand Paul; Frankie Holmes; Svetislava Vukelja; Michael Kasper; Sharon Wilks; Andrew Schneider; Richard McGee; Wally G. Meyer; Joyce A. O’Shaughnessy

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 170 KB
Volume: 116
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-008-0284-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy of sertraline for controlli

The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer

✍ Meng-Fen Wu; S. G. Hilsenbeck; Yee L. Tham; Rita Kramer; R. M. Elledge; J. C. Ch 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 204 KB

Factors implicated in the decision wheth

Factors implicated in the decision whether or not to join the tamoxifen trial in women at high familial risk of breast cancer

✍ E. Lovegrove; N. Rumsey; D. Harcourt; S.J. Cawthorn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 3 views

Why, given similar medical circumstances-high familial risk of breast cancer -will some women elect to join a trial of drugs designed to reduce that risk but others choose not to take part? The aim of this study was to identify measurable differences between women who elect to join a placebo-control